scholarly journals MRI Segmentation and Classification of Human Brain Using Deep Learning for Diagnosis of Alzheimer’s Disease: A Survey

Sensors ◽  
2020 ◽  
Vol 20 (11) ◽  
pp. 3243 ◽  
Author(s):  
Nagaraj Yamanakkanavar ◽  
Jae Young Choi ◽  
Bumshik Lee

Many neurological diseases and delineating pathological regions have been analyzed, and the anatomical structure of the brain researched with the aid of magnetic resonance imaging (MRI). It is important to identify patients with Alzheimer’s disease (AD) early so that preventative measures can be taken. A detailed analysis of the tissue structures from segmented MRI leads to a more accurate classification of specific brain disorders. Several segmentation methods to diagnose AD have been proposed with varying complexity. Segmentation of the brain structure and classification of AD using deep learning approaches has gained attention as it can provide effective results over a large set of data. Hence, deep learning methods are now preferred over state-of-the-art machine learning methods. We aim to provide an outline of current deep learning-based segmentation approaches for the quantitative analysis of brain MRI for the diagnosis of AD. Here, we report how convolutional neural network architectures are used to analyze the anatomical brain structure and diagnose AD, discuss how brain MRI segmentation improves AD classification, describe the state-of-the-art approaches, and summarize their results using publicly available datasets. Finally, we provide insight into current issues and discuss possible future research directions in building a computer-aided diagnostic system for AD.

2006 ◽  
Vol 14 (7S_Part_30) ◽  
pp. P1574-P1574
Author(s):  
Taeho Jo ◽  
Kwangsik Nho ◽  
Shannon L. Risacher ◽  
Jingwen Yan ◽  
Andrew J. Saykin

2006 ◽  
Vol 14 (7S_Part_19) ◽  
pp. P1067-P1068
Author(s):  
Pradeep Anand Ravindranath ◽  
Rema Raman ◽  
Tiffany W. Chow ◽  
Michael S. Rafii ◽  
Paul S. Aisen ◽  
...  

Author(s):  
Jingyan Qiu ◽  
Linjian Li ◽  
Yida Liu ◽  
Yingjun Ou ◽  
Yubei Lin

Alzheimer’s disease (AD) is one of the most common forms of dementia. The early stage of the disease is defined as Mild Cognitive Impairment (MCI). Recent research results have shown the prospect of combining Magnetic Resonance Imaging (MRI) scanning of the brain and deep learning to diagnose AD. However, the CNN deep learning model requires a large scale of samples for training. Transfer learning is the key to enable a model with high accuracy by using limited data for training. In this paper, DenseNet and Inception V4, which were pre-trained on the ImageNet dataset to obtain initialization values of weights, are, respectively, used for the graphic classification task. The ensemble method is employed to enhance the effectiveness and efficiency of the classification models and the result of different models are eventually processed through probability-based fusion. Our experiments were completely conducted on the Alzheimer’s Disease Neuroimaging Initiative (ADNI) public dataset. Only the ternary classification is made due to a higher demand for medical detection and diagnosis. The accuracies of AD/MCI/Normal Control (NC) of different models are estimated in this paper. The results of the experiments showed that the accuracies of the method achieved a maximum of 92.65%, which is a remarkable outcome compared with the accuracies of the state-of-the-art methods.


2021 ◽  
Vol 19 (11) ◽  
pp. 126-140
Author(s):  
Zahraa S. Aaraji ◽  
Hawraa H. Abbas

Neuroimaging data analysis has attracted a great deal of attention with respect to the accurate diagnosis of Alzheimer’s disease (AD). Magnetic Resonance Imaging (MRI) scanners have thus been commonly used to study AD-related brain structural variations, providing images that demonstrate both morphometric and anatomical changes in the human brain. Deep learning algorithms have already been effectively exploited in other medical image processing applications to identify features and recognise patterns for many diseases that affect the brain and other organs; this paper extends on this to describe a novel computer aided software pipeline for the classification and early diagnosis of AD. The proposed method uses two types of three-dimensional Convolutional Neural Networks (3D CNN) to facilitate brain MRI data analysis and automatic feature extraction and classification, so that pre-processing and post-processing are utilised to normalise the MRI data and facilitate pattern recognition. The experimental results show that the proposed approach achieves 97.5%, 82.5%, and 83.75% accuracy in terms of binary classification AD vs. cognitively normal (CN), CN vs. mild cognitive impairment (MCI) and MCI vs. AD, respectively, as well as 85% accuracy for multi class-classification, based on publicly available data sets from the Alzheimer’s disease Neuroimaging Initiative (ADNI).


2020 ◽  
Vol 10 (2) ◽  
pp. 84 ◽  
Author(s):  
Atif Mehmood ◽  
Muazzam Maqsood ◽  
Muzaffar Bashir ◽  
Yang Shuyuan

Alzheimer’s disease (AD) may cause damage to the memory cells permanently, which results in the form of dementia. The diagnosis of Alzheimer’s disease at an early stage is a problematic task for researchers. For this, machine learning and deep convolutional neural network (CNN) based approaches are readily available to solve various problems related to brain image data analysis. In clinical research, magnetic resonance imaging (MRI) is used to diagnose AD. For accurate classification of dementia stages, we need highly discriminative features obtained from MRI images. Recently advanced deep CNN-based models successfully proved their accuracy. However, due to a smaller number of image samples available in the datasets, there exist problems of over-fitting hindering the performance of deep learning approaches. In this research, we developed a Siamese convolutional neural network (SCNN) model inspired by VGG-16 (also called Oxford Net) to classify dementia stages. In our approach, we extend the insufficient and imbalanced data by using augmentation approaches. Experiments are performed on a publicly available dataset open access series of imaging studies (OASIS), by using the proposed approach, an excellent test accuracy of 99.05% is achieved for the classification of dementia stages. We compared our model with the state-of-the-art models and discovered that the proposed model outperformed the state-of-the-art models in terms of performance, efficiency, and accuracy.


2020 ◽  
Vol 10 (5) ◽  
pp. 1040-1048 ◽  
Author(s):  
Xianwei Jiang ◽  
Liang Chang ◽  
Yu-Dong Zhang

More than 35 million patients are suffering from Alzheimer’s disease and this number is growing, which puts a heavy burden on countries around the world. Early detection is of benefit, in which the deep learning can aid AD identification effectively and gain ideal results. A novel eight-layer convolutional neural network with batch normalization and dropout techniques for classification of Alzheimer’s disease was proposed. After data augmentation, the training dataset contained 7399 AD patient and 7399 HC subjects. Our eight-layer CNN-BN-DO-DA method yielded a sensitivity of 97.77%, a specificity of 97.76%, a precision of 97.79%, an accuracy of 97.76%, a F1 of 97.76%, and a MCC of 95.56% on the test set, which achieved the best performance in seven state-of-the-art approaches. The results strongly demonstrate that this method can effectively assist the clinical diagnosis of Alzheimer’s disease.


2017 ◽  
Vol 2 (1) ◽  
pp. 6
Author(s):  
Rania Ahmed Kadry Abdel Gawad Birry

Abstract—Alzheimer’s disease (AD) is a brain disease that causes a slow decline in memory, thinking and reasoning skills. It represents a major public health problem.  Magnetic Resonance Imaging (MRI) have shown that the brains of people with (AD) shrink significantly as the disease progresses. This shrinkage appears in specific brain regions such as the hippocampus which is a small, curved formation in the brain that plays an important role in the limbic system also involved in the formation of new memories and is also associated with learning and emotions.  Medical information on brain MRI is used in detecting the abnormalities in physiological structures. Structural MRI measurements can detect and follow the evolution of brain atrophy which is a marker of the disease progression; therefore, it allows diagnosis and prediction of AD.  The research’s main target is the early recognition of Alzheimer’s disease automatically, which will thereby avoid deterioration of the case resulting in complete brain damage stage.  Alzheimer’s disease yields visible changes in the brain structures. The aim is to recognize if the patient belongs to Alzheimer’s disease category or a normal healthy person at an early stage. Initially, image pre-processing and features extraction techniques are applied including data reduction using Discrete Cosine Transform (DCT) and Cropping, then traditional classification techniques like Euclidean Distance, Chebyshev Distance, Cosine Distance, City Block Distance, and Black pixel counter, were applied on the resulting vectors for classification. Image pre-processing includes noise reduction, Gray-scale conversion and binary scale conversion were applied for the MRI images. Feature extraction techniques follow including cropping and low spatial frequency components (DCT). This paper aims to automatically recognize and detect Alzheimer’s infected brain using MRI, without the need of clinical expert. This early recognition would be helpful to postpone the disease progression and maintain it at an almost steady stage. It was concluded after collecting a dataset of 50 MRI , 25 for normal MRI and  25 for AD MRI that Chebyshev Distance classifier yielded the highest success rate in the recognition of Alzheimer’s disease with accuracy 94% compared to other classification techniques used where, Euclidean Distance is 91.6%,  Cosine Distance is 86.8%, City block Distance is 89.6%, Correlation Distance is 86.4% and Black pixels counter is 90%.


2021 ◽  
Author(s):  
Ekin Yagis ◽  
Selamawet Workalemahu Atnafu ◽  
Alba García Seco de Herrera ◽  
Chiara Marzi ◽  
Marco Giannelli ◽  
...  

Abstract In recent years, 2D convolutional neural networks (CNNs) have been extensively used for the diagnosis of neurological diseases from magnetic resonance imaging (MRI) data due to their potential to discern subtle and intricate patterns. Despite the high performances reported in numerous studies, developing CNN models with good generalization abilities is still a challenging task due to possible data leakage introduced during cross-validation (CV). In this study, we quantitatively assessed the effect of a data leakage caused by 3D MRI data splitting based on a 2D slice-level using three 2D CNN models for the classification of patients with Alzheimer’s disease (AD) and Parkinson’s disease (PD). Our experiments showed that slice-level CV erroneously boosted the average slice level accuracy on the test set by 30% on Open Access Series of Imaging Studies (OASIS), 29% on Alzheimer’s Disease Neuroimaging Initiative (ADNI), 48% on Parkinson's Progression Markers Initiative (PPMI) and 55% on a local de-novo PD Versilia dataset. Further tests on a randomly labeled OASIS-derived dataset produced about 96% of (erroneous) accuracy (slice-level split) and 50% accuracy (subject-level split), as expected from a randomized experiment. Overall, the extent of the effect of an erroneous slice-based CV is severe, especially for small datasets.


Sign in / Sign up

Export Citation Format

Share Document